Emagix is focused on improving diagnosis and assessment measures by analyzing blood flow dynamics. Our proprietary software algorithm provides an objective assessment of which blood vessels are compromised, and to what extent. This vital tool gives clinicians the information they need to diagnose disease earlier, and to provide treatment that is better focused, in order to stop disease progression in its tracks. What if you could easily quantify leakage, flow and volume in retinal blood vessels? Our patented RetiCAD (Retinal Computer-Aided Diagnosis) software extracts unique data and new insights from retinal image sets acquired from routine fluorescein angiography procedures performed using conventional fundus cameras, and uses them to provide a highly accurate, sensitive and quantitative view of vascular health and integrity in the retina. Our technology transforms a highly subjective procedure into one that gives quantitative results, important new insights, and is up to 75% faster; all without requiring an investment in new equipment.